A detailed history of Quest Partners LLC transactions in Glaukos Corp stock. As of the latest transaction made, Quest Partners LLC holds 644 shares of GKOS stock, worth $56,292. This represents 0.01% of its overall portfolio holdings.

Number of Shares
644
Previous 11 5754.55%
Holding current value
$56,292
Previous $1.08 Million 6042.11%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$82.27 - $103.29 $52,076 - $65,382
633 Added 5754.55%
644 $66.5 Million
Q1 2025

May 14, 2025

BUY
$96.6 - $161.22 $1,062 - $1,773
11 New
11 $1.08 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.16B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.